Spectro Decypher Revenue
Architecture and Planning • 
1-4-5 Kanda Izumicho, 302 Kingo Building, Japan • 1-10 Employees
Spectro Decypher revenue & valuation
| Annual revenue | $85,555 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Architecture and Planning industry and current estimated revenues | $273,776 |
| Total funding | No funding |
Key Contact at Spectro Decypher
Shigeru Nakaoka
Managing Director
Company overview
| Headquarters | 1-4-5 Kanda Izumicho, 302 Kingo Building, Chiyoda-ku, Tokyo 1010024, JP |
| Phone number | +8120250125 |
| Website | |
| NAICS | 5413 |
| Keywords | MRI, Consulting, QMS, In Vitro Diagnostics, Data Science, Business Development, AI, Machine Learning, Chemical Analysis, NMR, Metabolomics, IVD, Regulatory Science, Clinical Study, Mass Analysis, Chemical Shift Imaging, Metabolome |
| Founded | 2018 |
| Employees | 1-10 |
Spectro Decypher Email Formats
Spectro Decypher uses 1 email format. The most common is {last name} (e.g., doe@spectrodecypher.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{last name} | doe@spectrodecypher.com | 100% |
About Spectro Decypher
Business Description SpectroDecypher provides a variety of business support for the development of laboratory drug products and pharmaceutical applications, as well as researching new measurement technologies in collaboration with research institutions. Practical support for marketing, clinical trials, and regulatory filings Not only venture companies and newcomers in the field of diagnostics, but also major manufacturers do not have enough know-how on the complexities of business development, clinical trials, regulatory filings, and dealing with authorities. We provide support for all aspects of business operations, including marketing and application policy planning, clinical trial design and implementation, research group management, PMDA compliance, and regulatory filing services for IVDs from overseas in Japan, which are essential for commercialization. (Speedy, high quality, reasonable price) Technical/product research support for diagnostic reagents Our team members, who are knowledgeable in the development of diagnostic reagents and drug discovery, and are also familiar with trends in medical devices, conduct product and technology research, mainly focusing on diagnostic reagents, testing methods, and testing devices (we have experience with major diagnostic reagent, textile, and chemical manufacturers, as well as bio-ventures). We also conduct seminars and write articles on diagnostic drug development and drug discovery. Development of biometric data measurement technology We are conducting joint research with national university research institutes on biometric data measurement technology, with a focus on the brain. In the future, we aim to apply the measurement technology of this research to animal experiments and clinical practice. A basic patent has been filed, and a second patent has also been filed. Shigeru Nakaoka(CEO) Support for diagnostics development / Medical collaboration (Worked at Abbott Japan and Fujirebio)
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Spectro Decypher has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Spectro Decypher has never raised funding before.
United States
United Kingdom
Australia
India
NetherlandsFrequently asked questions
4.8
40,000 users
